Analysis of Risk Factors for Low Bone Mineral Density in Patients with Inflammatory Bowel Disease.
10.4166/kjg.2010.55.4.237
- Author:
Jae Jung PARK
1
;
Sung Ae JUNG
;
Young Wook NOH
;
Min Jung KANG
;
Ji Min JUNG
;
Seong Eun KIM
;
Hye Kyung JUNG
;
Ki Nam SHIM
;
Tae Hun KIM
;
Kwon YOO
;
Il Hwan MOON
;
Young Sun HONG
Author Information
1. Department of Internal Medicine, Ewha Womans University School of Medicine, Ewha Medical Research Institute, Seoul, Korea. jassa@ewha.ac.kr
- Publication Type:Original Article ; English Abstract
- Keywords:
Inflammatory bowel disease;
Bone mineral density;
Crohn's disease;
Ulcerative colitis
- MeSH:
Absorptiometry, Photon;
Adolescent;
Adult;
Amino Acids/blood;
Body Mass Index;
*Bone Density;
Calcium/blood;
Colitis, Ulcerative/diagnosis/radiography;
Crohn Disease/diagnosis/radiography;
Female;
Glucocorticoids/therapeutic use;
Humans;
Inflammatory Bowel Diseases/diagnosis/drug therapy/*radiography;
Male;
Middle Aged;
Osteocalcin/blood;
Phosphorus/blood;
Prevalence;
Retrospective Studies;
Risk Factors
- From:The Korean Journal of Gastroenterology
2010;55(4):237-244
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: Several clinical risk factors for low bone mineral density (BMD) in the patients with inflammatory bowel disease (IBD) have been suggested. However, its prevalence and pathophysiology in Korean population have not been fully studied. The aim of this study was to investigate the prevalence and risk factors for low BMD in Korean IBD patient. METHODS: BMD of the lumbar spine and femur was evaluated using dual-energy X-ray absorptiometry in 30 patients with IBD. Biochemical parameters of bone metabolism, such as serum calcium, phosphorus, osteocalcin, and deoxypyridinoline were measured. The associations between low BMD and clinical parameters such as disease duration, disease activity, drug history, body mass index (BMI), and others were evaluated retrospectively using medical records. RESULTS: Low BMD at the lumbar spine or femur was observed in 63.3% of the patients, and there was no significant difference between the patients with Crohn's disease and ulcerative colitis. Clinical and biochemical parameters were irrelevant to BMD. In the patients without glucocorticoid treatment prior to BMD measurement, already 50.0% of patients had low BMD. CONCLUSIONS: Low BMD is a common feature in Korean IBD patients, even those who do not use glucocorticoid. The multiple factors may be involved in the pathogenesis of low BMD. Therefore, BMD should be examined in all IBD patients, irrespective of glucocorticoid treatment.
